MRCP2-4518
A 56-year-old male presents to the respiratory clinic with a dry cough and progressive shortness of breath. He has no significant medical history or exposure to environmental triggers and is a non-smoker who does not take any medications. Upon examination, bibasal inspiratory crackles and clubbing are noted, but there are no signs of cardiac failure. His current oxygen saturation level is 94% on air, and his last appointment revealed a known FVC of 70%. Pulmonary function testing shows a restrictive pattern, and a high resolution CT scan reveals bilateral lung volume loss with >5% honeycombing extensively at the bases and subpleural areas with evidence of peripheral traction bronchiectasis, extensively at the lung bases. Blood investigations for connective tissue disease have been negative. The patient has already been referred for pulmonary rehabilitation but is interested in knowing if any medication can potentially alter the course of his disease. What medication can be used to reduce functional decline in this patient population?